Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $514.7100 (-0.86%) ($514.4200 - $525.6900) on Thu. Nov. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.34% (three month average) | RSI | 44 | Latest Price | $514.7100(-0.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.5% a day on average for past five trading days. | Weekly Trend | REGN declines -2.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(42%) SPLV(37%) IVW(35%) SPY(35%) | Factors Impacting REGN price | REGN will decline at least -1.17% in a week (0% probabilities). VIXM(-21%) TBT(-7%) VXX(-6%) UUP(-6%) EDOC(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.17% (StdDev 2.34%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $560.47 | 5 Day Moving Average | $539.73(-4.64%) | 10 Day Moving Average | $551.82(-6.73%) | 20 Day Moving Average | $560.47(-8.16%) | To recent high | -18.3% | To recent low | 0% | Market Cap | $54.574b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |